NASDAQ:ELEV

Elevation Oncology (ELEV) News Today

$1.91

-0.91 (-32.27%)

(As of 06/9/2023 ET)

Compare

Today's Range: $1.50
▼
$2.07
50-Day Range: $1.71
▼
$5.06
52-Week Range: $0.72
▼
$5.89

Volume: 7.89 million shs
Average Volume: 4.29 million shs
Market Capitalization: $46.49 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $5.38

Get Elevation Oncology News Delivered to You Automatically

ELEV Media Mentions By Week

ELEV Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ELEV
News Sentiment
▼
0.60

0.78
▲
Average
Medical
News Sentiment

ELEV News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ELEV Articles
This Week
▼
13

1
▲
ELEV Articles
Average Week

Source

Source	Headline
	Elevation Oncology shares are trading lower after the company announced a $50 million public offering. benzinga.com - June 9 at 11:53 PM
	Elevation Oncology Shares Tumble Premarket After Stock Offering >ELEV marketwatch.com - June 9 at 11:53 PM
	Elevation Oncology Plummets on $50M Public Offering msn.com - June 9 at 11:53 PM
	Why Is Elevation Oncology (ELEV) Stock Down 26% Today? investorplace.com - June 9 at 10:11 AM
	Elevation Oncology slumps 25%, prices $50M public offering seekingalpha.com - June 9 at 3:51 AM
	Elevation Oncology slumps 25% on $50M public offering pricing msn.com - June 9 at 3:51 AM
	Elevation Oncology Announces Pricing of $50 Million Public Offering finance.yahoo.com - June 9 at 3:51 AM
	Elevation Oncology Shares Fall After Proposed Public Offering marketwatch.com - June 8 at 5:50 PM
	Elevation Oncology Announces Launch of Proposed Public Offering finance.yahoo.com - June 8 at 5:50 PM
	Head-To-Head Comparison: Exscientia (NASDAQ:EXAI) vs. Elevation Oncology (NASDAQ:ELEV) americanbankingnews.com - June 7 at 5:22 AM
	Wedbush Maintains Elevation Oncology (ELEV) Outperform Recommendation msn.com - June 6 at 8:53 AM
	Elevation Oncology Highlights First-in-Human Phase 1 SYSA1801 (EO-3021) Clinical Data to be Presented by Partner CSPC Pharmaceutical Group Limited at ASCO 2023 finance.yahoo.com - June 3 at 1:33 PM
	Elevation Oncology (NASDAQ:ELEV) Stock Rating Upgraded by SVB Securities americanbankingnews.com - June 1 at 2:58 AM
	Elevation Oncology (NASDAQ:ELEV) Upgraded by SVB Leerink to Outperform americanbankingnews.com - May 31 at 6:58 AM
	Steve Cohen's Point72 Disclosed 8.7% Stake In Elevation Oncology marketbeat.com - May 30 at 6:55 AM
	Elevation Oncology (NASDAQ:ELEV) and Freeline Therapeutics (NASDAQ:FRLN) Financial Comparison americanbankingnews.com - May 28 at 2:30 AM
	Elevation Oncology up 61% on early-stage data for gastric cancer treatment seekingalpha.com - May 26 at 5:40 PM
	Elevation Oncology Blasts Higher on New Cancer Treatment msn.com - May 26 at 5:40 PM
	Elevation Oncology (NASDAQ: ELEV) fool.com - May 26 at 12:39 PM
	Why Is Elevation Oncology (ELEV) Stock Up 57% Today? investorplace.com - May 26 at 11:13 AM
	SVB Leerink Weighs in on Elevation Oncology, Inc.'s Q2 2023 Earnings (NASDAQ:ELEV) americanbankingnews.com - May 20 at 2:22 AM
	Q2 2023 EPS Estimates for Elevation Oncology, Inc. Lifted by Analyst (NASDAQ:ELEV) americanbankingnews.com - May 20 at 2:22 AM
	Private equity firms among Elevation Oncology, Inc.'s (NASDAQ:ELEV) largest shareholders, saw gain in holdings value after stock jumped 34% last week finance.yahoo.com - May 19 at 9:28 AM
	Elevation Oncology Reports First Quarter 2023 Financial Results and Highlights Recent Business Achievements finance.yahoo.com - May 15 at 10:18 AM
	Elevation Oncology Highlights Clinical Data for SYSA1801 (EO-3021) to be Presented by Partner CSPC Pharmaceutical Group Limited at ASCO 2023 finance.yahoo.com - April 26 at 7:51 PM
	Elevation Oncology Presents EO-3021 Preclinical Proof-of-Concept Data and Highlights a Clinical Case Study in Claudin 18.2-Expressing Cancers at AACR 2023 finance.yahoo.com - April 17 at 4:13 PM
	Are Medical Stocks Lagging Elevation Oncology (ELEV) This Year? finance.yahoo.com - March 23 at 2:15 PM
	Are Medical Stocks Lagging Elevation Oncology (ELEV) This Year? finance.yahoo.com - March 23 at 2:15 PM
	Financial Comparison: Acumen Pharmaceuticals (NASDAQ:ABOS) vs. Elevation Oncology (NASDAQ:ELEV) americanbankingnews.com - March 22 at 2:22 AM
	Thinking about buying stock in Elevation Oncology, Credit Suisse, PacWest Bancorp, Atlas Air, or Marathon Digital? barrons.com - March 15 at 7:09 PM
	Elevation Oncology to Present at the American Association of Cancer Research (AACR) Annual Meeting 2023 finance.yahoo.com - March 14 at 6:08 PM
	Elevation Oncology Reports Fourth Quarter and Full Year 2022 Financial Results finance.yahoo.com - March 9 at 12:54 PM
	Elevation Oncology to Participate at Upcoming Investor Conferences finance.yahoo.com - March 1 at 12:44 PM
	Elevation Oncology to Present at the SVB Securities Global Biopharma Conference finance.yahoo.com - February 8 at 11:42 AM
	ELEV Elevation Oncology, Inc. seekingalpha.com - January 26 at 8:26 AM
	How Will Early 2023 Layoffs Affect These 5 Biotech Stocks? (ELEV) marketbeat.com - January 25 at 4:03 AM
	Elevation Oncology to Present at the 41st Annual J.P. Morgan Healthcare Conference finance.yahoo.com - January 9 at 8:02 AM
	Elevation Oncology CEO resigns as part of company prioritization effort msn.com - January 7 at 7:49 AM
	Elevation Oncology Announces Pipeline Prioritization, Realignment of Resources to Advance EO-3021 and CEO Transition finance.yahoo.com - January 6 at 12:40 PM
	Elevation Oncology to Participate at the JMP Securities Hematology and Oncology Summit finance.yahoo.com - November 30 at 8:25 AM
	Elevation Oncology Reports Third Quarter 2022 Financial Results and Highlights Recent Company Progress finance.yahoo.com - November 3 at 8:37 AM
	Merrimack Reports Second Quarter 2022 Financial Results finance.yahoo.com - August 4 at 5:42 PM
	Elevation Oncology to Participate at the Wedbush PacGrow Healthcare Conference finance.yahoo.com - August 3 at 10:04 AM
	Elevation Oncology Inc Stock News morningstar.com - July 30 at 5:46 AM
	Elevation Oncology Inc (ELEV) uk.investing.com - July 12 at 9:44 PM
	Short Volatility Alert: Elevation Oncology, Inc. uk.investing.com - July 12 at 9:44 PM
	marketbeat.com - May 31 at 9:52 AM
	marketbeat.com - May 31 at 9:32 AM
	Why Elevation Oncology Stock Is Rising uk.investing.com - May 27 at 11:36 AM
	Elevation Oncology Inc. barrons.com - May 27 at 6:35 AM

Get Elevation Oncology News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:ELEV) was last updated on 6/10/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Elevation Oncology (ELEV) News Today

ELEV Media Mentions By Week

ELEV Media Sentiment

ELEV News Coverage

Related Companies and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info